Effects of growth hormone and insulin-like growth factor I on T- and B- lymphocytes and immune function

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 86, Issue 423, 1997, Pages 76-79

  Geffner, M ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Growth hormone; Immune system; Insulin like growth factor; Lymphocytes

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HYDROGEN PEROXIDE; PHORBOL ESTER; SOMATOMEDIN C; SUPEROXIDE; HUMAN GROWTH HORMONE;

B LYMPHOCYTE; CELL PROLIFERATION; CONFERENCE PAPER; CYTOTOXICITY; GROWTH HORMONE DEFICIENCY; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOTHERAPY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE; THYMOCYTE; ADULT; ANIMAL; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

ADULT; ANIMALS; B-LYMPHOCYTES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; T-LYMPHOCYTES;

EID: 0030781034     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Smith PE. The effect of hypophysectomy upon the involution of the thymus in the rat. Anat Rec 1930;47:119-29
2. Pierpaoli W, Sorkin E. Hormones and immunologic capacity. I. Effect of heterologous anti-growth hormone (ASTH) antiserum on thymus and peripheral lymphatic tissue in mice. J Immunol 1968;101:1036-43
3. Gelato MC. Growth hormone-insulin-like growth factor I and immune function. Trends Endocrinol Metab 1993;4:106-10
4. Wit JM, Kooijman R, Rijkers GT, Zegers BJM. Immunological findings in growth hormone-treated patients. Horm Res 1993; 39:107-10
5. Rapaport R. Immunomodulation by growth hormone in humans. In: Berczi I, Szélenyi J, editors. Advances in psychoneuroimmunology. New York: Plenum Press, 1994:83-98
6. Auernhammer CJ, Strasburger CJ. Effects of growth hormone and insulin-like growth factor I on the immune system. Eur J Endocrinol 1995;133:635-45
7. Clark R. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr Rev 1997;18:1-23
8. Berczi I, Nagy E, de Toledo SM, Matusik RJ, Friesen HG. Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J Immunol 1991;146:2201-6
9. Goya RG, Gagnerault MC, Leite de Moraes MC, Savino W, Dardenne M. In vivo effects of growth hormone on thymus function in aging mice. Brain Behav Immun 1992;6:341-54
10. Lawler Goff B, Roth JA, Arp LH, Incefy GS. Growth hormone treatment stimulates thymulin production in aged dogs. Clin Exp Immunol 1987;68:580-7
11. Murphy WJ, Durum SK, Longo DL. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice. Proc Natl Acad Sci USA 1992;89:4481-5
12. Murphy WJ, Durum SK, Anver M, Frazier M, Longo DL. Recombinant human growth hormone promotes lymphocyte engraftment in immunodeficient mice and results in increased incidence of human Epstein Barr virus-induced B-cell lymphoma. Brain Behav Immun 1992;6:355-64
13. Kelley KW, Davila DR, Brief S, Simon J, Arkins S. A pituitary-thymus connection during aging. In: Pierpaoli W, Spector NH, Jankovic B, editors. Neuroimmunomodulation: interventions in aging and cancer, vol. 521. New York: New York Academy of Sciences, 1988:88-98
14. Kelley KW, Arkins S, Li YM. Growth hormone, prolactin, and insulin-like growth factors: new jobs for old players. Brain Behav Immun 1992;6:317-26
15. Lesniak MA, Roth J, Gorden P, Gavin JR III. Human growth hormone radioreceptor assay using cultured human lymphocytes. Nature (New Biol) 1973;241:20-2
16. Rapaport R, Sills IN, Green L, Barrett P, Labus J, Skuza KA, et al. Detection of human growth hormone receptors on IM-9 cells and peripheral blood mononuclear cell subsets by flow cytometry: correlation with growth hormone-binding protein levels. J Clin Endocrinol Metab 1995;80:2612-19
17. Bozzola M, Valtorta A, Moretta A, Cisternino M, Biscaldi I, Schimpff RM. In vitro and in vivo effect of growth hormone on cytotoxic activity. J Pediatr 1990;117:596-9
18. Mercola KE, Cline MJ, Golde DW. Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. Blood. 1981;58:337-40
19. Geffner ME, Bersch N, Lippe BM, Rosenfeld RG, Hintz RL, Golde DW. Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor I. J Clin Endocrinol Metab 1990;71:464-9
20. Geffner ME, Golde DW, Lippe BM, Kaplan SA, Bersch N, Li CH. Tissues of the Laron dwarf are sensitive to insulin-like growth factor I but not to growth hormone. J Clin Endocrinol Metab 1987;64:1042-7
21. Merimee TJ, Grant MB, Broder CM, Cavalli-Sforza LL. Insulin-like growth factor secretion by human B-lymphocytes: a comparison of cells from normal and pygmy subjects. J Clin Endocrinol Metab 1989;69:978-84
22. Geffner ME, Bailey RC, Bersch N, Vera JC, Golde DW. Insulin-like growth factor-I unresponsiveness in an Efe Pygmy. Biochem Biophys Res Comm 1993;193:1216-26
23. Geffner ME, Bersch N, Bailey RC, Golde DW. Insulin-like growth factor-I resistance in immortalized T-cell lines from African Efe Pygmies. J Clin Endocrinol Metab 1995; 80:3732-8
24. Hattori Y, Vera JC, Rivas CI, Bersch N, Bailey RC, Geffner ME, et al. Decreased insulin-like growth factor-1 (IGF-1) receptor expression and function in immortalized African Pygmy T-cells. J Clin Endocrinol Metab 1996;81:2257-63
25. Cortez AB, Van Dop C, Bailey RC, Bersch N, Scott M, Golde DW, et al. IGF-I resistance in virus-transformed B-lymphocytes from African Efe Pygmies. Biochem Mol Med 1996;58:31-6
26. 2. J Immunol 1995;154:1909-18
27. Fu Y-K, Arkins S, Shang Wang B, Kelley KW. A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion. J Immunol 1991;146:1602-8
28. Fleisher TA, White RM, Broder S, Nissley SP, Blaese RM, Mulvihill JJ, et al. X-linked hypogammaglobulinemia and isolated growth hormone deficiency. N Engl J Med 1980; 302:1429-34
29. Wu H, Devi R, Malarkey WB. Localization of growth hormone messenger ribonucleic acid in the human immune system - a clinical research center study. J Clin Endocrinol Metab 1996;81:1278-82
30. Hattori N, Shimatsu A, Sugita M, Kumagai S, Imura H. Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem Biophys Res Comm 1990;168:396-401
31. Guler H-P, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988;85:4889-93
32. Wood TL. Gene-targeting and transgenic approaches to IGF and IGF binding protein function. Am J Physiol 1995;269 (Endocrinol Metab):E613-22
33. Tapson VF, Boni-Schnetzler M, Pilch PF, Center DM, Berman JS. Structural and functional characterization of the human T-lymphocyte receptor for insulin-like growth factor I in vitro. J Clin Invest 1988;82:950-7
34. Stuart CA, Meehan RT, Neale LS, Cintron NM, Furlanetto RW. Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab 1991;72:1117-22
35. Lee PDK, Rosenfeld RG, Hintz RL, Smith SD. Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J Clin Endocrinol Metab 1986;62:28-35
36. Werner H, Woloschak M, Stannard B, Shen-Orr Z, Roberts CT, LeRoith D. The insulin-like growth factor I receptor: molecular biology, heterogeneity and regulation. In: LeRoith D, editor. Insulin-like growth factors: molecular and cellular aspects. Boca Raton: CRC, 1991:17-48
37. Geffner ME, Bersch N, Golde DW. Insulin and IGF-I stimulate normal and virally-transformed T-lymphocyte cell growth in vitro. Brain Behav Immun 1992;6:377-86
38. Backeljauw, Underwood LE. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome - a clinical research center study. J Clin Endocrinol Metab 1996;81:3312-17
39. Geffner ME, Yeh DY, Landaw EM, Scott ML, Stiehm ER, Bryson YJ, et al. In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children. Pediatr Res 1993;34:66-72
40. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993;77:956-62
41. Krentz AJ, Koster FT, Crist DM, Finn K, Johnson LZ, Boyle PJ, et al. Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J Acq Imm Def 1993;6:245-51
42. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1994;78:404-10
43. Lee PDK, Pivarnik JM, Bukar JG, Muurahainen N, Berry PS, Skolnik PR, et al. A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone for wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1996;81:2968-75